News Release

Assessment of changes in cancer treatment during the first year of the pandemic

JAMA Oncology

Peer-Reviewed Publication

JAMA Network

About The Study: In this study including 3.5 million patients diagnosed with cancer, a significant deficit was noted in the number of cancer treatments provided in the first year of the COVID-19 pandemic in the U.S. Data indicated that this deficit in the number of cancer treatments provided was associated with decreases in the number of cancer diagnoses, not changes in treatment strategies. 

Authors: Leticia M. Nogueira, Ph.D., M.P.H., of the American Cancer Society in Kennesaw, Georgia, is the corresponding author. 

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaoncol.2023.4513)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.4513?guestAccessKey=528780f4-5acf-47e9-af2a-3ca7c517f6ef&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110923


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.